no image available Dickens & Co. "Breaking New Ground: Blinatumomab Gains Priority Review for Aggressive Blood Cancer" "Novel Immunotherapy Shows Promise in Treating Relapsed or Refractory Acute Lymphoblastic Leukemia" Price: 29.00€